Pharmaceutical Manufacturing of Fluconazole Tablets

The contract entails the full-scale manufacturing of Fluconazole Tablets identified by NDC16714-0694-01 and NSN 6505013198249, covering all stages from formulation and tablet pressing to packaging and comprehensive batch testing. Production must adhere strictly to regulatory standards set by the Food and Drug Administration and the Department of Defense, ensuring the final product meets rigorous quality, safety, and efficacy requirements for military use. The work is classified as a subcontract under NAICS code 325412, indicating specialization in pharmaceutical preparations, and is managed by the Defense Logistics Agency under the Department of Defense. The contract was posted on July 21, 2026, and is associated with the procurement vehicle SPE2DX25D9900 and delivery order SPE2DP26F7918. While no specific point of contact or place of performance is provided, the work is expected to be conducted in facilities certified for federal pharmaceutical production, with all processes subject to audit and compliance verification. The contract does not specify a set-aside type, implying it is open to general competition among qualified manufacturers capable of fulfilling DoD’s stringent pharmaceutical standards.